The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling

Nature Reviews Immunology

Volumn 12, Issue 12, 2012, Pages 833-844

  Vandenabeele, Peter ^a,b   Bertrand, Mathieu J M ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; INFLAMMASOME; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; UBIQUITIN PROTEIN LIGASE E3;

DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; INFLAMMATORY CELL; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; APOPTOSIS; DROSOPHILA MELANOGASTER; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INHIBITOR OF APOPTOSIS PROTEINS; MICE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 84870242006     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3325     Document Type: Review

References (109)

1. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
2. Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821-832 (2010).
3. Kersse, K., Bertrand, M. J., Lamkanfi, M. & Vandenabeele, P. NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev. 22, 257-276 (2011).
4. Jiang, X. & Chen, Z. J. The role of ubiquitylation in immune defence and pathogen evasion. Nature Rev. Immunol. 12, 35-48 (2012).
5. Chen, G., Shaw, M. H., Kim, Y. G. & Nunez, G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4, 365-398 (2009).
6. Sun, S. C. Deubiquitylation and regulation of the immune response. Nature Rev. Immunol. 8, 501-511 (2008).
7. Komander, D. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953 (2009).
8. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 (2007). (Pubitemid 350233662)
9. Deveraux, Q. L., Takahashi, R., Salvesen, G. S. & Reed, J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304 (1997). (Pubitemid 27317977)
10. Srinivasula, S. M. & Ashwell, J. D. IAPs: what's in a name? Mol. Cell 30, 123-135 (2008). (Pubitemid 351626688)
11. Gyrd-Hansen, M. & Meier, P. IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer. Nature Rev. Cancer 10, 561-574 (2010).
12. Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M. & Ashwell, J. D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877 (2000). (Pubitemid 30257739)
13. Vanlangenakker, N. et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ. 18, 656-665 (2011).
14. He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100-1111 (2009).
15. Geserick, P. et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J. Cell Biol. 187, 1037-1054 (2009).
16. Tenev, T. et al. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 43, 432-448 (2011).
17. Feoktistova, M. et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43, 449-463 (2011).
18. Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131, 682-693 (2007). (Pubitemid 350103599)
19. Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131, 669-681 (2007). (Pubitemid 350087204)
20. Bertrand, M. J. et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30, 689-700 (2008). (Pubitemid 351818251)
21. Varfolomeev, E. et al. Cellular inhibitors of apoptosis are global regulators of NF-κB and MAPK activation by members of the TNF family of receptors. Sci. Signal. 5, ra22 (2012).
22. Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295-24299 (2008).
23. Mahoney, D. J. et al. Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc. Natl Acad. Sci. USA 105, 11778-11783 (2008).
24. Moulin, M. et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J. 31, 1679-1691 (2012).
25. Bertrand, M. J. et al. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30, 789-801 (2009).
26. This study provides the first evidence for non-redundant ubiquitylation-dependent functions of cIAP1 and cIAP2 in NOD1 and NOD2 signalling by functioning as K63 ubiquitin ligases for RIPK2. 26. Damgaard, R. B. et al. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 46, 746-758 (2012).
27. This paper shows that XIAP positively regulates NOD2-mediated immunity by promoting RIPK2 ubiquitylation and by inducing recruitment of LUBAC to the receptor-signalling complex. 27. Krieg, A. et al. XIAP mediates NOD signaling via interaction with RIP2. Proc. Natl Acad. Sci. USA 106, 14524-14529 (2009).
28. Tseng, P. H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nature Immunol. 11, 70-75 (2010).
29. This study demonstrates that cIAP1 and cIAP2-induced proteosomal degradation of TRAF3 is required for TLR4-mediated pro-inflammatory cytokine induction by facilitating translocation of the MYD88 complex to the cytosol where it activates MAPK signalling pathways. 29. Mao, A. P. et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J. Biol. Chem. 285, 9470-9476 (2010).
30. Labb, K., McIntire, C. R., Doiron, K., Leblanc, P. M. & Saleh, M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 35, 897-907 (2011).
31. Vince, J. E. et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36, 215-227 (2012).
32. References 30 and 31 provide contrasting evidence for a role of XIAP, cIAP1 and cIAP2 in inflammasome activation and pro-IL-1β processing. 32. Silke, J. The regulation of TNF signalling: what a tangled web we weave. Curr. Opin. Immunol. 23, 620-626 (2011).
33. Vucic, D., Dixit, V. M. & Wertz, I. E. Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nature Rev. Mol. Cell Biol. 12, 439-452 (2011).
34. Crook, N. E., Clem, R. J. & Miller, L. K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67, 2168-2174 (1993). (Pubitemid 23088392)
35. Eckelman, B. P. & Salvesen, G. S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 281, 3254-3260 (2006). (Pubitemid 43845937)
36. Eckelman, B. P., Salvesen, G. S. & Scott, F. L. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7, 988-994 (2006). (Pubitemid 44480512)
37. Choi, Y. E. et al. The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing. J. Biol. Chem. 284, 12772-12782 (2009).
38. Blankenship, J. W. et al. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2. Biochem. J. 417, 149-160 (2009).
39. Gyrd-Hansen, M. et al. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis. Nature Cell Biol. 10, 1309-1317 (2008).
40. Lopez, J. et al. CARD-mediated autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. Mol. Cell 42, 569-583 (2011).
41. Lemaitre, B. & Hoffmann, J. The host defense of Drosophila melanogaster. Annu. Rev. Immunol. 25, 697-743 (2007). (Pubitemid 46697922)
42. Ferrandon, D., Imler, J. L., Hetru, C. & Hoffmann, J. A. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nature Rev. Immunol. 7, 862-874 (2007). (Pubitemid 350006241)
43. Valanne, S., Kleino, A., Myllymaki, H., Vuoristo, J. & Ramet, M. Iap2 is required for a sustained response in the Drosophila Imd pathway. Dev. Comp. Immunol. 31, 991-1001 (2007). (Pubitemid 47095005)
44. Huh, J. R. et al. The Drosophila inhibitor of apoptosis (IAP) DIAP2 is dispensable for cell survival, required for the innate immune response to gram-negative bacterial infection, and can be negatively regulated by the reaper/hid/grim family of IAP-binding apoptosis inducers. J. Biol. Chem. 282, 2056-2068 (2007). (Pubitemid 47076727)
45. Leulier, F., Lhocine, N., Lemaitre, B. & Meier, P. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol. Cell. Biol. 26, 7821-7831 (2006). (Pubitemid 44630984)
46. Kleino, A. et al. Inhibitor of apoptosis 2 and TAK1-binding protein are components of the Drosophila Imd pathway. EMBO J. 24, 3423-3434 (2005). (Pubitemid 41486780)
47. Gesellchen, V., Kuttenkeuler, D., Steckel, M., Pelte, N. & Boutros, M. An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila. EMBO Rep. 6, 979-984 (2005). (Pubitemid 41521955)
48. References 45-47 provide the first in vitro and in vivo evidence for a role of an IAP (DIAP2) in the regulation of innate immune PRR (PGRP-LC) signalling. 48. Paquette, N. et al. Caspase-mediated cleavage, IAP binding, and ubiquitination: linking three mechanisms crucial for Drosophila NF-κB signaling. Mol. Cell 37, 172-182 (2010).
49. Meinander, A. et al. Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling. EMBO J. 31, 2770-2783 (2012).
50. References 48 and 49 provided the molecular mechanism accounting for the role of DIAP2 in the IMD pathway, which involves K63-linked ubiquitylation of IMD (reference 48) and DREDD (reference 49). IMD and DREDD are both required for PGRP-LC-induced innate immune responses. 50. Choe, K. M., Lee, H. & Anderson, K. V. Drosophila peptidoglycan recognition protein LC (PGRP-LC) acts as a signal-transducing innate immune receptor. Proc. Natl Acad. Sci. USA 102, 1122-1126 (2005). (Pubitemid 40170736)
51. Georgel, P. et al. Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev. Cell 1, 503-514 (2001). (Pubitemid 33586102)
52. Naitza, S. et al. The Drosophila immune defense against gram-negative infection requires the death protein dFADD. Immunity 17, 575-581 (2002). (Pubitemid 35351503)
53. Leulier, F., Vidal, S., Saigo, K., Ueda, R. & Lemaitre, B. Inducible expression of double-stranded RNA reveals a role for dFADD in the regulation of the antibacterial response in Drosophila adults. Curr. Biol. 12, 996-1000 (2002). (Pubitemid 34703329)
54. Leulier, F., Rodriguez, A., Khush, R. S., Abrams, J. M. & Lemaitre, B. The Drosophila caspase Dredd is required to resist gram-negative bacterial infection. EMBO Rep. 1, 353-358 (2000).
55. Wu, G. et al. Structural basis of IAP recognition by Smac/DIABLO. Nature 408, 1008-1012 (2000). (Pubitemid 32101651)
56. Zhou, R. et al. The role of ubiquitination in Drosophila innate immunity. J. Biol. Chem. 280, 34048-34055 (2005). (Pubitemid 41443127)
57. Zhuang, Z. H. et al. Drosophila TAB2 is required for the immune activation of JNK and NF-κB. Cell Signal 18, 964-970 (2006).
58. Silverman, N. et al. Immune activation of NF-κB and JNK requires Drosophila TAK1. J. Biol. Chem. 278, 48928-48934 (2003).
59. Vidal, S. et al. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses. Genes Dev. 15, 1900-1912 (2001).
60. Silverman, N. et al. A Drosophila IκB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 14, 2461-2471 (2000).
61. Rutschmann, S. et al. Role of Drosophila IKKγ in a toll-independent antibacterial immune response. Nature Immunol. 1, 342-347 (2000).
62. Lu, Y., Wu, L. P. & Anderson, K. V. The antibacterial arm of the Drosophila innate immune response requires an IκB kinase. Genes Dev. 15, 104-110 (2001). (Pubitemid 32060686)
63. Wu, C. J., Conze, D. B., Li, T. Srinivasula, S. M. & Ashwell, J. D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [corrected]. Nature Cell Biol. 8, 398-406 (2006).
64. Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004). (Pubitemid 39141781)
65. Geuking, P., Narasimamurthy, R., Lemaitre, B., Basler, K. & Leulier, F. A non-redundant role for Drosophila Mkk4 and hemipterous/Mkk7 in TAK1-mediated activation of JNK. PLoS ONE 4, e7709 (2009).
66. Erturk-Hasdemir, D. et al. Two roles for the Drosophila IKK complex in the activation of Relish and the induction of antimicrobial peptide genes. Proc. Natl Acad. Sci. USA 106, 9779-9784 (2009).
67. Stoven, S., Ando, I., Kadalayil, L., Engstrom, Y. & Hultmark, D. Activation of the Drosophila NF-κB factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 1, 347-352 (2000).
68. Stoven, S. et al. Caspase-mediated processing of the Drosophila NF-κB factor Relish. Proc. Natl Acad. Sci. USA 100, 5991-5996 (2003). (Pubitemid 36576919)
69. Thevenon, D. et al. The Drosophila ubiquitin-specific protease dUSP36/Scny targets IMD to prevent constitutive immune signaling. Cell Host Microbe 6, 309-320 (2009).
70. Tsichritzis, T. et al. A Drosophila ortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defense. Development 134, 2605-2614 (2007). (Pubitemid 47225957)
71. Bauler, L. D., Duckett, C. S. & O'Riordan, M. X. XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog. 4, e1000142 (2008).
72. Conze, D. B. et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25, 3348-3356 (2005). (Pubitemid 40464334)
73. Conte, D. et al. Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival. Mol. Cell. Biol. 26, 699-708 (2006). (Pubitemid 43090921)
74. Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T. & Thompson, C. B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21, 3604-3608 (2001). (Pubitemid 32381796)
75. Kobayashi, K. et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199 (2002). (Pubitemid 34246479)
76. Chin, A. I. et al. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416, 190-194 (2002). (Pubitemid 34246478)
77. Inohara, N. et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274, 14560-14567 (1999).
78. Hasegawa, M. et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation. EMBO J. 27, 373-383 (2008). (Pubitemid 351161652)
79. Hitotsumatsu, O. et al. The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 28, 381-390 (2008). (Pubitemid 351343859)
80. Yang, Y. et al. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 282, 36223-36229 (2007).
81. Bertrand, M. J. et al. cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS ONE 6, e22356 (2011).
82. Kim, J. Y., Omori, E., Matsumoto, K., Nunez, G. & Ninomiya-Tsuji, J. TAK1 is a central mediator of NOD2 signaling in epidermal cells. J. Biol. Chem. 283, 137-144 (2008).
83. Hsu, Y. M. et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nature Immunol. 8, 198-205 (2007).
84. Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887 (2006). (Pubitemid 44607032)
85. Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 136, 1098-1109 (2009).
86. Tokunaga, F. et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nature Cell Biol. 11, 123-132 (2009).
87. Schmukle, A. C. & Walczak, H. No one can whistle a symphony alone - how different ubiquitin linkages cooperate to orchestrate NF-κB activity. J. Cell Sci. 125, 549-559 (2012).
88. Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844 (2009).
89. Gerlach, B. et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596 (2011).
90. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 11, 373-384 (2010).
91. Kenneth, N. S. et al. An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. Biochem. J. 443, 355-359 (2012).
92. Matsuzawa, A. et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663-668 (2008).
93. Weber, A. et al. Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ. 17, 942-951 (2010).
94. Estornes, Y. et al. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ. 19, 1482-1494 (2012).
95. Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006). (Pubitemid 43083141)
96. Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208-211 (2006). (Pubitemid 43083142)
97. Saha, S. K. et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25, 3257-3263 (2006). (Pubitemid 44141784)
98. Fitzgerald, K. A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunol. 4, 491-496 (2003). (Pubitemid 36592443)
99. Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151 (2003). (Pubitemid 36583100)
100. Yoshida, R. et al. TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J. Biol. Chem. 283, 36211-36220 (2008).
101. Rajput, A. et al. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34, 340-351 (2011).
102. Gardam, S. et al. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117, 4041-4051 (2011).
103. Maelfait, J. et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8. J. Exp. Med. 205, 1967-1973 (2008).
104. Gringhuis, S. I. et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nature Immunol. 13, 246-254 (2012).
105. Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225 (2011).
106. Jin, Z. et al. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137, 721-735 (2009).
107. Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509 (1998). (Pubitemid 28101113)
108. Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117-121 (2011).
109. Petersen, S. L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445-456 (2007). (Pubitemid 350064365)